Midihealth
Director/Sr. Director of Employer Sales
Remote. Posted 2 months ago
The role
The Director/Sr. Director of Employer Sales will drive new business and revenue growth across employers nationally. This role involves owning a national territory and managing the end-to-end sales process from identification to close.
What you will do
- Own territory and revenue target.
- Develop and execute a sales strategy to identify, engage, and close employers.
- Build a high-quality pipeline using outreach and industry networks.
- Lead complex sales cycles end to end.
- Navigate the benefits ecosystem using relationships with employers, brokers, consultants, and health plans.
- Position the value proposition in a consultative way.
- Maintain accurate forecast, pipeline hygiene, and deal management in HubSpot.
- Help shape the employer sales playbook by providing market and buyer insights.
Required qualifications
- 10+ years of experience in employer healthcare benefits sales.
- Proven track record of meeting or exceeding quota and closing complex employer deals.
- Strong relationships across the HR and employee benefits community, including consultants and brokers.
- Ability to navigate complex organizations and build influence from Director-level to C-suite.
- Highly organized and disciplined about forecasting, CRM hygiene, follow-up, and deal management.
- Strong communicator and relationship builder.
- Self-directed, resourceful, resilient, and motivated by ambitious goals.
- Passionate about improving healthcare for women.
Nice to have
- Experience within digital health, healthcare services, or a related high-growth environment.
Benefits
- Competitive compensation
- Meaningful equity
Before you apply
- Midi is unable to provide visa sponsorship.
- All Candidates must be authorized to work in the United States without current or future sponsorship needs.
About the company
Midi Health is building a virtual care clinic for women navigating perimenopause, menopause, and other midlife health challenges. The company is backed by investors including Google Ventures, Semper Virens, and Emerson Collective.